TapewireFind a company

person · Reporting owner

Lewis Sara Grootwassink

Disclosed activity across 4 companies

Tapewire entity
42614
SEC CIK
0001165970

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
FREEPORT-MCMORAN INCFCX · Entity 2905DirectorJune 01, 2026June 02, 2026
HEALTHPEAK PROPERTIES, INC.DOC · Entity 3364DirectorMay 06, 2026May 08, 2026
PS BUSINESS PARKS, INC./MDPSB · Entity 125076DirectorJune 15, 2018June 18, 2018
WEYERHAEUSER COWY · Entity 3314DirectorMay 15, 2026May 19, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

FREEPORT-MCMORAN INC

Report date June 01, 2026 · Filed June 02, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect34,000 Reported balance After 2026-06-01 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2026-06-01 · Grant · Acquired 2,800 · Balance 34,000

F1: Represents a grant of Common Stock Restricted Stock Units ("RSUs").

F2: Amount beneficially owned following the reported transaction includes 7,300 RSUs.

Filing footnotes · ownership attribution and instrument terms

F1: Represents a grant of Common Stock Restricted Stock Units ("RSUs").

F2: Amount beneficially owned following the reported transaction includes 7,300 RSUs.

HEALTHPEAK PROPERTIES, INC.

Report date May 06, 2026 · Filed May 08, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect56,488 Reported balance After 2026-05-06 transaction · row 1
1 source row

Row 1 · 2026-05-06 · Grant · Acquired 9,744 · Balance 56,488

F1: Restricted stock units vest in full on the earlier of the first anniversary of the May 6, 2026 grant date or the Company's next annual meeting of stockholders.

Common StockSEC Table I · non-derivativeIndirectTrust22,000 Reported balance Holding disclosure · report date 2026-05-06 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 22,000

Common StockSEC Table I · non-derivativeIndirectIRA9,000 Reported balance Holding disclosure · report date 2026-05-06 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 9,000

Filing footnotes · ownership attribution and instrument terms

F1: Restricted stock units vest in full on the earlier of the first anniversary of the May 6, 2026 grant date or the Company's next annual meeting of stockholders.

PS BUSINESS PARKS, INC./MD

Report date June 15, 2018 · Filed June 18, 2018

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect3,000 Ending reported balance After 2018-06-15 transaction · row 7
7 source rows · reconciled sequence

Row 1 · 2018-06-15 · Exercise / conversion · Acquired 1,068 · Balance 4,068

F1: On December 15, 2014, PSB declared a special dividend, payable on December 30, 2014. As a result, pursuant to anti-dilution provisions of PSB's 2012 Equity and Performance-Based Compensation Plan, an option for 2,000 shares of common stock held by the reporting person on December 30, 2014 became exercisable for an additional 68 shares of common stock.

Row 2 · 2018-06-15 · Exercise / conversion · Acquired 2,000 · Balance 6,068

Row 3 · 2018-06-15 · Exercise / conversion · Acquired 1,600 · Balance 7,668

Row 4 · 2018-06-15 · Exercise / conversion · Acquired 1,200 · Balance 8,868

Row 5 · 2018-06-15 · Exercise / conversion · Acquired 800 · Balance 9,668

Row 6 · 2018-06-15 · Exercise / conversion · Acquired 400 · Balance 10,068

Row 7 · 2018-06-15 · Sale · Disposed 7,068 · Balance 3,000

F2: Represents weighted average price. These shares were sold at prices ranging from $124.00 and $124.83. Full information regarding the number of shares purchased at each separate price will be provided by the reporting person upon request to the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $66.00 · Expires 2022-04-30Direct0 Reported balance After 2018-06-15 transaction · row 8 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 8 · 2018-06-15 · Exercise / conversion · Disposed 1,068 · Balance 0

F3: Stock Option granted pursuant to the 2012 Equity and Performance-Based Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from the date of grant.

F4: This option was previously reported as an option for 2,000 shares of common stock at an exercise price of $68.25, but was adjusted to reflect the special dividend declared by PSB on December 15, 2014.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $79.10 · Expires 2023-05-06Direct0 Reported balance After 2018-06-15 transaction · row 9 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 9 · 2018-06-15 · Exercise / conversion · Disposed 2,000 · Balance 0

F3: Stock Option granted pursuant to the 2012 Equity and Performance-Based Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from the date of grant.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $82.84 · Expires 2024-04-28Direct400 Reported balance After 2018-06-15 transaction · row 10 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 10 · 2018-06-15 · Exercise / conversion · Disposed 1,600 · Balance 400

F3: Stock Option granted pursuant to the 2012 Equity and Performance-Based Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from the date of grant.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $80.13 · Expires 2025-04-28Direct800 Reported balance After 2018-06-15 transaction · row 11 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 11 · 2018-06-15 · Exercise / conversion · Disposed 1,200 · Balance 800

F3: Stock Option granted pursuant to the 2012 Equity and Performance-Based Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from the date of grant.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $96.89 · Expires 2026-04-26Direct1,200 Reported balance After 2018-06-15 transaction · row 12 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 12 · 2018-06-15 · Exercise / conversion · Disposed 800 · Balance 1,200

F3: Stock Option granted pursuant to the 2012 Equity and Performance-Based Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from the date of grant.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $121.57 · Expires 2027-04-25Direct1,600 Reported balance After 2018-06-15 transaction · row 13 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 13 · 2018-06-15 · Exercise / conversion · Disposed 400 · Balance 1,600

F3: Stock Option granted pursuant to the 2012 Equity and Performance-Based Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from the date of grant.

Filing footnotes · ownership attribution and instrument terms

F1: On December 15, 2014, PSB declared a special dividend, payable on December 30, 2014. As a result, pursuant to anti-dilution provisions of PSB's 2012 Equity and Performance-Based Compensation Plan, an option for 2,000 shares of common stock held by the reporting person on December 30, 2014 became exercisable for an additional 68 shares of common stock.

F2: Represents weighted average price. These shares were sold at prices ranging from $124.00 and $124.83. Full information regarding the number of shares purchased at each separate price will be provided by the reporting person upon request to the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer.

F3: Stock Option granted pursuant to the 2012 Equity and Performance-Based Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from the date of grant.

F4: This option was previously reported as an option for 2,000 shares of common stock at an exercise price of $68.25, but was adjusted to reflect the special dividend declared by PSB on December 15, 2014.

WEYERHAEUSER CO

Report date May 15, 2026 · Filed May 19, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Share EquivalentsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct80,213.77 Reported balance After 2026-05-15 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-05-15 · Grant · Acquired 7,832 · Balance 80,213.77

F1: The stock equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 7,832 restricted stock units into an equal number of stock equivalents. The restricted stock units (rounded down to the nearest whole unit) represent the equity portion of the annual retainer fee in the amount of $180,000, with the number of units determined by dividing the dollar amount of the fee by $22.98, the average of the high ($23.40) and low ($22.56) price of the Issuer's common stock on the date of the grant. Additional stock equivalents accrue as and when dividends are paid on the Issuer's common stock. Stock equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F2: Reported holdings include stock equivalents acquired since the Reporting Person's last filing on Form 4 from dividend reinvestment transactions exempt from Section 16 of the Securities Exchange Act of 1934, as amended.

Filing footnotes · ownership attribution and instrument terms

F1: The stock equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 7,832 restricted stock units into an equal number of stock equivalents. The restricted stock units (rounded down to the nearest whole unit) represent the equity portion of the annual retainer fee in the amount of $180,000, with the number of units determined by dividing the dollar amount of the fee by $22.98, the average of the high ($23.40) and low ($22.56) price of the Issuer's common stock on the date of the grant. Additional stock equivalents accrue as and when dividends are paid on the Issuer's common stock. Stock equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F2: Reported holdings include stock equivalents acquired since the Reporting Person's last filing on Form 4 from dividend reinvestment transactions exempt from Section 16 of the Securities Exchange Act of 1934, as amended.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 01, 2026 Filed Jun 2, 2026 21:34 UTC FREEPORT-MCMORAN INC FCX · Entity 2905 GrantCommon Stock 2,800 $0.00 $0.00
Disclosure

SEC source: 0001214659-26-007082 · marketforms-73338.xml · nonDerivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,000

F1 · kind: Represents a grant of Common Stock Restricted Stock Units ("RSUs").

F2 · balance_after: Amount beneficially owned following the reported transaction includes 7,300 RSUs.

Read SEC document
May 15, 2026 Filed May 19, 2026 21:20 UTC WEYERHAEUSER CO WY · Entity 3314 GrantShare Equivalents · Derivative 7,832 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001165970-26-000005 · ownership.xml · derivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,213.77

Underlying: Common · 7,832 shares

Expires not disclosed

F1 · shares: The stock equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 7,832 restricted stock units into an equal number of stock equivalents. The restricted stock units (rounded down to the nearest whole unit) represent the equity portion of the annual retainer fee in the amount of $180,000, with the number of units determined by dividing the dollar amount of the fee by $22.98, the average of the high ($23.40) and low ($22.56) price of the Issuer's common stock on the date of the grant. Additional stock equivalents accrue as and when dividends are paid on the Issuer's common stock. Stock equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F1 · derivative.exercise_date: The stock equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 7,832 restricted stock units into an equal number of stock equivalents. The restricted stock units (rounded down to the nearest whole unit) represent the equity portion of the annual retainer fee in the amount of $180,000, with the number of units determined by dividing the dollar amount of the fee by $22.98, the average of the high ($23.40) and low ($22.56) price of the Issuer's common stock on the date of the grant. Additional stock equivalents accrue as and when dividends are paid on the Issuer's common stock. Stock equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F1 · derivative.expiration_date: The stock equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 7,832 restricted stock units into an equal number of stock equivalents. The restricted stock units (rounded down to the nearest whole unit) represent the equity portion of the annual retainer fee in the amount of $180,000, with the number of units determined by dividing the dollar amount of the fee by $22.98, the average of the high ($23.40) and low ($22.56) price of the Issuer's common stock on the date of the grant. Additional stock equivalents accrue as and when dividends are paid on the Issuer's common stock. Stock equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F2 · balance_after: Reported holdings include stock equivalents acquired since the Reporting Person's last filing on Form 4 from dividend reinvestment transactions exempt from Section 16 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 06, 2026 Filed May 8, 2026 00:08 UTC HEALTHPEAK PROPERTIES, INC. DOC · Entity 3364 GrantCommon Stock 9,744 $0.00 $0.00
Disclosure

SEC source: 0001165970-26-000002 · wk-form4_1778198905.xml · nonDerivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,488

F1 · shares: Restricted stock units vest in full on the earlier of the first anniversary of the May 6, 2026 grant date or the Company's next annual meeting of stockholders.

Read SEC document
December 17, 2025 Filed Dec 18, 2025 22:23 UTC WEYERHAEUSER CO WY · Entity 3314 PurchaseCommon 4,500 $23.61 $106,226.10
Disclosure

SEC source: 0001193125-25-325117 · ownership.xml · nonDerivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,978

Read SEC document
August 11, 2025 Filed Aug 13, 2025 21:21 UTC WEYERHAEUSER CO WY · Entity 3314 PurchaseCommon 4,000 $25.29 $101,140.00
Disclosure

SEC source: 0000950170-25-108170 · ownership.xml · nonDerivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,478

F1 · balance_after: Excludes 4,096 shares previously owned directly and currenlty owned indirectly by trust.

Read SEC document
June 01, 2025 Filed Jun 3, 2025 21:27 UTC FREEPORT-MCMORAN INC FCX · Entity 2905 GrantCommon Stock 4,900 $0.00 $0.00
Disclosure

SEC source: 0001214659-25-008783 · marketforms-69751.xml · nonDerivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,200

F1 · kind: Represents a grant of Common Stock Restricted Stock Units ("RSUs").

F2 · balance_after: Amount beneficially owned following the reported transaction includes 9,400 RSUs.

Read SEC document
May 09, 2025 Filed May 13, 2025 21:31 UTC WEYERHAEUSER CO WY · Entity 3314 GrantShare Equivalents · Derivative 6,849 $26.28 Strike: $0.00 $179,991.72
Disclosure

SEC source: 0000950170-25-070553 · ownership.xml · derivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,947.103

Underlying: Common · 6,849 shares

Expires not disclosed

F1 · shares: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 6,849 restricted stock units into an equal number of share equivalents. The restricted stock units (rounded down to the nearest whole unit) represent the equity portion of the annual retainer fee in the amount of $180,000, with the number of units determined by dividing the dollar amount of the fee by $26.28, the average of the high ($26.50) and low ($26.06) price of the issuer's common stock on the date of the grant. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F1 · price: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 6,849 restricted stock units into an equal number of share equivalents. The restricted stock units (rounded down to the nearest whole unit) represent the equity portion of the annual retainer fee in the amount of $180,000, with the number of units determined by dividing the dollar amount of the fee by $26.28, the average of the high ($26.50) and low ($26.06) price of the issuer's common stock on the date of the grant. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F1 · derivative.exercise_date: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 6,849 restricted stock units into an equal number of share equivalents. The restricted stock units (rounded down to the nearest whole unit) represent the equity portion of the annual retainer fee in the amount of $180,000, with the number of units determined by dividing the dollar amount of the fee by $26.28, the average of the high ($26.50) and low ($26.06) price of the issuer's common stock on the date of the grant. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F1 · derivative.expiration_date: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 6,849 restricted stock units into an equal number of share equivalents. The restricted stock units (rounded down to the nearest whole unit) represent the equity portion of the annual retainer fee in the amount of $180,000, with the number of units determined by dividing the dollar amount of the fee by $26.28, the average of the high ($26.50) and low ($26.06) price of the issuer's common stock on the date of the grant. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F2 · balance_after: Reported holdings include share equivalents acquired since the Reporting Person's last filing on Form 4 from dividend reinvestment transactions exempt from Section 16 of the Securities Exchange Act of 1934, as amended.

Read SEC document
April 28, 2025 Filed Apr 28, 2025 21:52 UTC HEALTHPEAK PROPERTIES, INC. DOC · Entity 3364 PurchaseCommon Stock 6,000 $17.66 $105,938.40
Disclosure

SEC source: 0001628280-25-020387 · wk-form4_1745877140.xml · nonDerivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · IRA

Disclosed balance after: 9,000

Read SEC document
April 25, 2025 Filed Apr 29, 2025 21:06 UTC HEALTHPEAK PROPERTIES, INC. DOC · Entity 3364 GrantCommon Stock 10,657 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-020758 · wk-form4_1745960762.xml · nonDerivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,744

F1 · shares: Restricted stock units vest in full on the earlier of the first anniversary of the April 25, 2025 grant date or the Company's next annual meeting of stockholders.

Read SEC document
June 01, 2024 Filed Jun 4, 2024 21:38 UTC FREEPORT-MCMORAN INC FCX · Entity 2905 GrantCommon Stock 3,500 $0.00 $0.00
Disclosure

SEC source: 0001214659-24-010577 · marketforms-66153.xml · nonDerivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,300

F1 · kind: Represents a grant of Common Stock Restricted Stock Units ("RSUs").

F2 · balance_after: Amount beneficially owned following the reported transaction includes 8,000 RSUs.

Read SEC document
May 10, 2024 Filed May 13, 2024 23:01 UTC WEYERHAEUSER CO WY · Entity 3314 GrantShare Equivalents · Derivative 5,790 $31.09 Strike: $0.00 $179,982.15
Disclosure

SEC source: 0000950170-24-058959 · ownership.xml · derivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,467.344

Underlying: Common · 5,790 shares

Expires not disclosed

F1 · derivative.exercise_price: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 5,790 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $180,000, with the number of units determined by dividing the dollar amount of the fees by $31.085, the average of the high ($31.27) and low ($30.90) price of the Issuer's common stock on the date of the grant. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F1 · shares: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 5,790 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $180,000, with the number of units determined by dividing the dollar amount of the fees by $31.085, the average of the high ($31.27) and low ($30.90) price of the Issuer's common stock on the date of the grant. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F1 · price: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 5,790 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $180,000, with the number of units determined by dividing the dollar amount of the fees by $31.085, the average of the high ($31.27) and low ($30.90) price of the Issuer's common stock on the date of the grant. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F1 · derivative.exercise_date: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 5,790 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $180,000, with the number of units determined by dividing the dollar amount of the fees by $31.085, the average of the high ($31.27) and low ($30.90) price of the Issuer's common stock on the date of the grant. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F1 · derivative.expiration_date: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 5,790 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $180,000, with the number of units determined by dividing the dollar amount of the fees by $31.085, the average of the high ($31.27) and low ($30.90) price of the Issuer's common stock on the date of the grant. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F2 · balance_after: Reported holdings include share equivalents acquired since the Reporting Person's last filing on Form 4 from dividend reinvestment transactions exempt from Section 16 of the Securities Exchange Act of 1934, as amended.

Read SEC document
April 26, 2024 Filed Apr 30, 2024 21:32 UTC HEALTHPEAK PROPERTIES, INC. DOC · Entity 3364 GrantCommon Stock 9,575 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-019400 · wk-form4_1714512731.xml · nonDerivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,087

F1 · shares: Restricted stock units vest in full on the earlier of the first anniversary of the April 26, 2024 grant date or the Company's next annual meeting of stockholders.

Read SEC document
March 04, 2024 Filed Mar 4, 2024 22:46 UTC HEALTHPEAK PROPERTIES, INC. DOC · Entity 3364 PurchaseCommon Stock 18,000 $16.71 $300,780.00
Disclosure

SEC source: 0001628280-24-008624 · wk-form4_1709592351.xml · nonDerivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Trust

Disclosed balance after: 22,000

Read SEC document
June 01, 2023 Filed Jun 2, 2023 21:39 UTC FREEPORT-MCMORAN INC FCX · Entity 2905 GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-033949 · doc4.xml · nonDerivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,800

F1 · security: Amount beneficially owned following the reported transaction includes 9,500 common stock restricted stock units ("RSUs").

F2 · kind: Represents a grant of RSUs.

Read SEC document
May 12, 2023 Filed May 15, 2023 21:41 UTC WEYERHAEUSER CO WY · Entity 3314 GrantShare Equivalents · Derivative 5,706 $29.79 Strike: $0.00 $169,981.74
Disclosure

SEC source: 0001209191-23-029580 · doc4.xml · derivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,115.923

Underlying: Common · 5,706 shares

Expires not disclosed

F1 · derivative.exercise_price: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 5,706 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $170,000, with the number of units determined by dividing the dollar amount of the fees by $29.79, the average of the high ($29.99) and low ($29.59) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F1 · shares: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 5,706 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $170,000, with the number of units determined by dividing the dollar amount of the fees by $29.79, the average of the high ($29.99) and low ($29.59) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F1 · price: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 5,706 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $170,000, with the number of units determined by dividing the dollar amount of the fees by $29.79, the average of the high ($29.99) and low ($29.59) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F1 · derivative.exercise_date: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 5,706 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $170,000, with the number of units determined by dividing the dollar amount of the fees by $29.79, the average of the high ($29.99) and low ($29.59) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F1 · derivative.expiration_date: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 5,706 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $170,000, with the number of units determined by dividing the dollar amount of the fees by $29.79, the average of the high ($29.99) and low ($29.59) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F2 · balance_after: Reported holdings include shares acquired since the Reporting Person's last filing on Form 4 from dividend reinvestment transactions exempt from Section 16 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 12, 2023 Filed May 15, 2023 21:51 UTC FREEPORT-MCMORAN INC FCX · Entity 2905 PurchaseCommon Stock 4,000 $34.90 $139,596.80
Disclosure

SEC source: 0001209191-23-029590 · doc4.xml · nonDerivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,800

F1 · security: Amount beneficially owned following the reported transaction includes 4,500 common stock restricted stock units.

Read SEC document
April 28, 2023 Filed May 1, 2023 22:46 UTC HEALTHPEAK PROPERTIES, INC. PEAK · Entity 3364 GrantCommon Stock 8,193 $0.00 $0.00
Disclosure

SEC source: 0001628280-23-014706 · wf-form4_168298118792456.xml · nonDerivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,512

F1 · shares: Restricted stock units vest in full on the earlier of the first anniversary of the April 28, 2023 grant date or the Company's next annual meeting of stockholders.

Read SEC document
March 15, 2023 Filed Mar 16, 2023 20:59 UTC HEALTHPEAK PROPERTIES, INC. PEAK · Entity 3364 PurchaseCommon Stock 4,000 $21.43 $85,728.80
Disclosure

SEC source: 0001628280-23-008339 · wf-form4_167900037390359.xml · nonDerivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Trust

Disclosed balance after: 4,000

Read SEC document
August 03, 2022 Filed Aug 4, 2022 21:29 UTC FREEPORT-MCMORAN INC FCX · Entity 2905 PurchaseCommon Stock 3,000 $28.79 $86,355.00
Disclosure

SEC source: 0001209191-22-044446 · doc4.xml · nonDerivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,800

F1 · security: Amount beneficially owned following the reported transaction includes 4,500 common stock restricted stock units.

Read SEC document
June 01, 2022 Filed Jun 2, 2022 21:29 UTC FREEPORT-MCMORAN INC FCX · Entity 2905 GrantCommon Stock 4,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-033647 · doc4.xml · nonDerivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,800

F1 · security: Amount beneficially owned following the reported transaction includes 8,300 common stock restricted stock units ("RSUs").

F2 · kind: Represents a grant of RSUs.

Read SEC document
May 16, 2022 Filed May 17, 2022 19:48 UTC WEYERHAEUSER CO WY · Entity 3314 GrantShare Equivalents · Derivative 4,191 $38.18 Strike: $0.00 $159,991.43
Disclosure

SEC source: 0001209191-22-029562 · doc4.xml · derivative · entry 4

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,113.052

Underlying: Common · 4,191 shares

Expires not disclosed

F4 · derivative.exercise_price: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 4,191 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $160,000, with the number of units determined by dividing the dollar amount of the fees by $38.175, the average of the high ($38.76) and low ($37.59) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F4 · shares: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 4,191 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $160,000, with the number of units determined by dividing the dollar amount of the fees by $38.175, the average of the high ($38.76) and low ($37.59) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F4 · price: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 4,191 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $160,000, with the number of units determined by dividing the dollar amount of the fees by $38.175, the average of the high ($38.76) and low ($37.59) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F4 · derivative.exercise_date: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 4,191 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $160,000, with the number of units determined by dividing the dollar amount of the fees by $38.175, the average of the high ($38.76) and low ($37.59) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F4 · derivative.expiration_date: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 4,191 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $160,000, with the number of units determined by dividing the dollar amount of the fees by $38.175, the average of the high ($38.76) and low ($37.59) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F2 · balance_after: Reported holdings include shares acquired since the Reporting Person's last filing on Form 4 from dividend reinvestment transactions exempt from Section 16 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 14, 2022 Filed May 17, 2022 19:48 UTC WEYERHAEUSER CO WY · Entity 3314 Tax withholdingCommon 80 $38.71 $3,096.80
Disclosure

SEC source: 0001209191-22-029562 · doc4.xml · nonDerivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,574

F1 · shares: These shares (rounded down to the nearest whole share) are being withheld to cover taxes for a restricted stock unit vesting.

F2 · balance_after: Reported holdings include shares acquired since the Reporting Person's last filing on Form 4 from dividend reinvestment transactions exempt from Section 16 of the Securities Exchange Act of 1934, as amended.

F3 · balance_after: The Reporting Person received a cash payment in lieu of fractional shares.

Read SEC document
April 28, 2022 Filed May 2, 2022 23:04 UTC HEALTHPEAK PROPERTIES, INC. PEAK · Entity 3364 GrantCommon Stock 5,258 $0.00 $0.00
Disclosure

SEC source: 0001628280-22-011836 · wf-form4_165153265171092.xml · nonDerivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,319

F1 · shares: Restricted stock units vest in full on the earlier of the first anniversary of the April 28, 2022 grant date or the Company's next annual meeting of stockholders.

Read SEC document
August 02, 2021 Filed Aug 4, 2021 21:49 UTC FREEPORT-MCMORAN INC FCX · Entity 2905 GrantCommon Stock 3,800 $0.00 $0.00
Disclosure

SEC source: 0001246360-21-000878 · form.xml · nonDerivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,300

F1 · security: Amount beneficially owned following the reported transaction includes 3,800 common stock restricted stock units ("RSUs").

F2 · kind: Represents a grant of RSUs.

Read SEC document
May 14, 2021 Filed May 18, 2021 23:53 UTC WEYERHAEUSER CO WY · Entity 3314 GrantCommon 3,900 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-033789 · doc4.xml · nonDerivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,378

F1 · shares: These shares were granted pursuant to a restricted stock unit award that vests 100% one year after the grant date. These shares (rounded down to the nearest whole share) represent the equity portion of the annual retainer fee in the amount of $150,000.00, with the number of restricted stock units determined by dividing the dollar amount of the fee by $38.455, the average of the high ($38.75) and low ($38.16) price of the issuer's common stock on the date of the grant.

Read SEC document
April 29, 2021 Filed May 3, 2021 22:33 UTC HEALTHPEAK PROPERTIES, INC. PEAK · Entity 3364 GrantCommon Stock 4,724 $0.00 $0.00
Disclosure

SEC source: 0001628280-21-008684 · wf-form4_162008118429570.xml · nonDerivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,061

F1 · shares: Restricted stock units vest in full on the earlier of the first anniversary of the April 29, 2021 grant date or the Company's next annual meeting of stockholders.

Read SEC document
May 15, 2020 Filed May 19, 2020 01:03 UTC WEYERHAEUSER CO WY · Entity 3314 GrantShare Equivalents · Derivative 7,186 $17.26 Strike: $0.00 $123,994.43
Disclosure

SEC source: 0001209191-20-030303 · doc4.xml · derivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,719.283

Underlying: Common · 7,186 shares

Expires not disclosed

F1 · derivative.exercise_price: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 7,186 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $124,000, with the number of units determined by dividing the dollar amount of the fees by $17.255, the average of the high ($17.69) and low ($16.82) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F1 · shares: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 7,186 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $124,000, with the number of units determined by dividing the dollar amount of the fees by $17.255, the average of the high ($17.69) and low ($16.82) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F1 · price: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 7,186 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $124,000, with the number of units determined by dividing the dollar amount of the fees by $17.255, the average of the high ($17.69) and low ($16.82) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F1 · derivative.exercise_date: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 7,186 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $124,000, with the number of units determined by dividing the dollar amount of the fees by $17.255, the average of the high ($17.69) and low ($16.82) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F1 · derivative.expiration_date: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 7,186 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $124,000, with the number of units determined by dividing the dollar amount of the fees by $17.255, the average of the high ($17.69) and low ($16.82) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F2 · balance_after: Reported holdings include shares acquired since the Reporting Person's last filing on Form 4 from dividend reinvestment transactions exempt from Section 16 of the Securities Exchange Act of 1934, as amended.

Read SEC document
April 30, 2020 Filed May 4, 2020 22:08 UTC HEALTHPEAK PROPERTIES, INC. PEAK · Entity 3364 GrantCommon Stock 6,121 $0.00 $0.00
Disclosure

SEC source: 0001628280-20-006298 · wf-form4_158863011059425.xml · nonDerivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,337

F1 · shares: Restricted stock units vest in full on the earlier of the first anniversary of the April 30, 2020 grant date or the Company's next annual meeting of stockholders.

Read SEC document
March 17, 2020 Filed Mar 19, 2020 00:41 UTC WEYERHAEUSER CO WY · Entity 3314 PurchaseCommon 5,000 $17.96 $89,799.50
Disclosure

SEC source: 0001209191-20-020137 · doc4.xml · nonDerivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,478

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:59 UTC HEALTHPEAK PROPERTIES, INC. PEAK · Entity 3364 PurchaseCommon Stock 3,000 $32.13 $96,377.40
Disclosure

SEC source: 0001628280-20-002806 · wf-form4_158327637827691.xml · nonDerivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · 401(k) Plan

Disclosed balance after: 3,000

F1 · price: The price reported in Column 4 is a weighted average sales price. These shares were purchased in multiple transactions at sale prices ranging from $32.1256 to $32.13. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.

Read SEC document
December 16, 2019 Filed Feb 6, 2020 01:11 UTC WEYERHAEUSER CO WY · Entity 3314 OtherCommon 45 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-007044 · doc5.xml · nonDerivative · entry 2

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By IRA

Disclosed balance after: 45

F1 · shares: Represents shares acquired as part of an inheritance.

Read SEC document
December 16, 2019 Filed Feb 6, 2020 01:11 UTC WEYERHAEUSER CO WY · Entity 3314 OtherCommon 72 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-007044 · doc5.xml · nonDerivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,478

F1 · shares: Represents shares acquired as part of an inheritance.

Read SEC document
November 07, 2019 Filed Nov 12, 2019 23:01 UTC HEALTHPEAK PROPERTIES, INC. PEAK · Entity 3364 GrantCommon Stock 2,216 $0.00 $0.00
Disclosure

SEC source: 0001628280-19-014010 · wf-form4_157359969586711.xml · nonDerivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,216

F1 · shares: Represents a prorated initial grant of restricted stock units, which vests in full on April 23, 2020, the anticipated date of the issuer's next annual meeting of stockholders.

Read SEC document
May 17, 2019 Filed May 21, 2019 00:17 UTC WEYERHAEUSER CO WY · Entity 3314 GrantShare Equilvalents · Derivative 6,101 $24.59 Strike: $0.00 $149,993.09
Disclosure

SEC source: 0001225208-19-008258 · doc4.xml · derivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,723.683

Underlying: Common · 6,101 shares

Expires not disclosed

F1 · derivative.exercise_price: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 6,101 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $150,000, with the number of units determined by dividing the dollar amount of the fees by $24.585, the average of the high ($24.87) and low ($24.30) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F1 · shares: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 6,101 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $150,000, with the number of units determined by dividing the dollar amount of the fees by $24.585, the average of the high ($24.87) and low ($24.30) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F1 · price: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 6,101 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $150,000, with the number of units determined by dividing the dollar amount of the fees by $24.585, the average of the high ($24.87) and low ($24.30) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F1 · derivative.exercise_date: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 6,101 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $150,000, with the number of units determined by dividing the dollar amount of the fees by $24.585, the average of the high ($24.87) and low ($24.30) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F1 · derivative.expiration_date: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 6,101 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $150,000, with the number of units determined by dividing the dollar amount of the fees by $24.585, the average of the high ($24.87) and low ($24.30) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F2 · balance_after: Reported holdings include shares acquired since the Reporting Person's last filing on Form 4 from dividend reinvestment transactions exempt from Section 16 of the Securities Exchange Act of 1934, as amended.

Read SEC document
June 15, 2018 Filed Jun 18, 2018 16:52 UTC PS BUSINESS PARKS, INC./MD PSB · Entity 125076 Exercise / conversionStock Option (right to buy) · Derivative 400 $0.00 Strike: $121.57 $0.00
Disclosure

SEC source: 0001140361-18-028993 · doc1.xml · derivative · entry 13

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,600

Underlying: Common Stock · 400 shares

Expires 2027-04-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock Option granted pursuant to the 2012 Equity and Performance-Based Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from the date of grant.

Read SEC document
June 15, 2018 Filed Jun 18, 2018 16:52 UTC PS BUSINESS PARKS, INC./MD PSB · Entity 125076 Exercise / conversionStock Option (right to buy) · Derivative 800 $0.00 Strike: $96.89 $0.00
Disclosure

SEC source: 0001140361-18-028993 · doc1.xml · derivative · entry 12

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,200

Underlying: Common Stock · 800 shares

Expires 2026-04-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock Option granted pursuant to the 2012 Equity and Performance-Based Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from the date of grant.

Read SEC document
June 15, 2018 Filed Jun 18, 2018 16:52 UTC PS BUSINESS PARKS, INC./MD PSB · Entity 125076 Exercise / conversionStock Option (right to buy) · Derivative 1,200 $0.00 Strike: $80.13 $0.00
Disclosure

SEC source: 0001140361-18-028993 · doc1.xml · derivative · entry 11

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 800

Underlying: Common Stock · 1,200 shares

Expires 2025-04-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock Option granted pursuant to the 2012 Equity and Performance-Based Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from the date of grant.

Read SEC document
June 15, 2018 Filed Jun 18, 2018 16:52 UTC PS BUSINESS PARKS, INC./MD PSB · Entity 125076 Exercise / conversionStock Option (right to buy) · Derivative 1,600 $0.00 Strike: $82.84 $0.00
Disclosure

SEC source: 0001140361-18-028993 · doc1.xml · derivative · entry 10

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400

Underlying: Common Stock · 1,600 shares

Expires 2024-04-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock Option granted pursuant to the 2012 Equity and Performance-Based Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from the date of grant.

Read SEC document
June 15, 2018 Filed Jun 18, 2018 16:52 UTC PS BUSINESS PARKS, INC./MD PSB · Entity 125076 Exercise / conversionStock Option (right to buy) · Derivative 2,000 $0.00 Strike: $79.10 $0.00
Disclosure

SEC source: 0001140361-18-028993 · doc1.xml · derivative · entry 9

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,000 shares

Expires 2023-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock Option granted pursuant to the 2012 Equity and Performance-Based Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from the date of grant.

Read SEC document
June 15, 2018 Filed Jun 18, 2018 16:52 UTC PS BUSINESS PARKS, INC./MD PSB · Entity 125076 Exercise / conversionStock Option (right to buy) · Derivative 1,068 $0.00 Strike: $66.00 $0.00
Disclosure

SEC source: 0001140361-18-028993 · doc1.xml · derivative · entry 8

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,068 shares

Expires 2022-04-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock Option granted pursuant to the 2012 Equity and Performance-Based Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from the date of grant.

F4 · derivative.exercise_price: This option was previously reported as an option for 2,000 shares of common stock at an exercise price of $68.25, but was adjusted to reflect the special dividend declared by PSB on December 15, 2014.

F4 · shares: This option was previously reported as an option for 2,000 shares of common stock at an exercise price of $68.25, but was adjusted to reflect the special dividend declared by PSB on December 15, 2014.

Read SEC document
June 15, 2018 Filed Jun 18, 2018 16:52 UTC PS BUSINESS PARKS, INC./MD PSB · Entity 125076 SaleCommon Stock 7,068 $124.45 $879,587.16
Disclosure

SEC source: 0001140361-18-028993 · doc1.xml · nonDerivative · entry 7

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,000

F2 · price: Represents weighted average price. These shares were sold at prices ranging from $124.00 and $124.83. Full information regarding the number of shares purchased at each separate price will be provided by the reporting person upon request to the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer.

Read SEC document
June 15, 2018 Filed Jun 18, 2018 16:52 UTC PS BUSINESS PARKS, INC./MD PSB · Entity 125076 Exercise / conversionCommon Stock 400 $121.57 $48,628.00
Disclosure

SEC source: 0001140361-18-028993 · doc1.xml · nonDerivative · entry 6

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,068

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 15, 2018 Filed Jun 18, 2018 16:52 UTC PS BUSINESS PARKS, INC./MD PSB · Entity 125076 Exercise / conversionCommon Stock 800 $96.89 $77,512.00
Disclosure

SEC source: 0001140361-18-028993 · doc1.xml · nonDerivative · entry 5

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,668

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 15, 2018 Filed Jun 18, 2018 16:52 UTC PS BUSINESS PARKS, INC./MD PSB · Entity 125076 Exercise / conversionCommon Stock 1,200 $80.13 $96,156.00
Disclosure

SEC source: 0001140361-18-028993 · doc1.xml · nonDerivative · entry 4

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,868

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 15, 2018 Filed Jun 18, 2018 16:52 UTC PS BUSINESS PARKS, INC./MD PSB · Entity 125076 Exercise / conversionCommon Stock 1,600 $82.84 $132,544.00
Disclosure

SEC source: 0001140361-18-028993 · doc1.xml · nonDerivative · entry 3

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,668

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 15, 2018 Filed Jun 18, 2018 16:52 UTC PS BUSINESS PARKS, INC./MD PSB · Entity 125076 Exercise / conversionCommon Stock 2,000 $79.10 $158,200.00
Disclosure

SEC source: 0001140361-18-028993 · doc1.xml · nonDerivative · entry 2

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,068

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 15, 2018 Filed Jun 18, 2018 16:52 UTC PS BUSINESS PARKS, INC./MD PSB · Entity 125076 Exercise / conversionCommon Stock 1,068 $66.00 $70,488.00
Disclosure

SEC source: 0001140361-18-028993 · doc1.xml · nonDerivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,068

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On December 15, 2014, PSB declared a special dividend, payable on December 30, 2014. As a result, pursuant to anti-dilution provisions of PSB's 2012 Equity and Performance-Based Compensation Plan, an option for 2,000 shares of common stock held by the reporting person on December 30, 2014 became exercisable for an additional 68 shares of common stock.

Read SEC document
May 18, 2018 Filed May 22, 2018 22:21 UTC WEYERHAEUSER CO WY · Entity 3314 GrantShare Equilvalents · Derivative 7,150 $36.36 Strike: $0.00 $259,938.25
Disclosure

SEC source: 0001225208-18-009752 · doc4.xml · derivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,505.03

Underlying: Common · 7,150 shares

Expires not disclosed

F1 · derivative.exercise_price: The reported share equivalents were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer into an equal number of share equivalents 3,850 restricted stock units, representing the equity portion of the annual retainer fee in the amount of $140,000, with the number of units determined by dividing the dollar amount of the fees by $36.355 (average of the high ($36.48) and low ($36.23) price of the Issuer's common stock on the fee payment date). The Reporting Person also elected to defer cash fees of $120,000 by conversion into a number of share equivalents determined by dividing the dollar amount of the fees by $36.355. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F1 · derivative.exercise_date: The reported share equivalents were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer into an equal number of share equivalents 3,850 restricted stock units, representing the equity portion of the annual retainer fee in the amount of $140,000, with the number of units determined by dividing the dollar amount of the fees by $36.355 (average of the high ($36.48) and low ($36.23) price of the Issuer's common stock on the fee payment date). The Reporting Person also elected to defer cash fees of $120,000 by conversion into a number of share equivalents determined by dividing the dollar amount of the fees by $36.355. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F1 · derivative.expiration_date: The reported share equivalents were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer into an equal number of share equivalents 3,850 restricted stock units, representing the equity portion of the annual retainer fee in the amount of $140,000, with the number of units determined by dividing the dollar amount of the fees by $36.355 (average of the high ($36.48) and low ($36.23) price of the Issuer's common stock on the fee payment date). The Reporting Person also elected to defer cash fees of $120,000 by conversion into a number of share equivalents determined by dividing the dollar amount of the fees by $36.355. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.

F2 · balance_after: Reported holdings include shares acquired since the Reporting Person's last filing on Form 4 from dividend reinvestment transactions exempt from Section 16 of the Securities Exchange Act of 1934, as amended.

Read SEC document
April 24, 2018 Filed Apr 26, 2018 16:29 UTC PS BUSINESS PARKS, INC./MD PSB · Entity 125076 GrantStock Option (right to buy) · Derivative 2,000 $0.00 Strike: $115.45 $0.00
Disclosure

SEC source: 0001140361-18-019765 · doc1.xml · derivative · entry 1

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

Underlying: Common Stock · 2,000 shares

Expires 2028-04-24

F1 · security: Stock option granted pursuant to the 2012 Equity and Performance-Based Incentive Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from the date of grant.

Read SEC document
September 13, 2017 Filed Sep 14, 2017 16:57 UTC PS BUSINESS PARKS, INC./MD PSB · Entity 125076 Exercise / conversionStock Option (right to buy) · Derivative 1,000 $0.00 Strike: $66.00 $0.00
Disclosure

SEC source: 0001140361-17-035534 · doc1.xml · derivative · entry 10

Lewis Sara Grootwassink · CIK 0001165970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,068

Underlying: Common Stock · 1,000 shares

Expires 2022-04-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · security: Stock Option granted pursuant to the 2012 Equity and Performance-Based Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from the date of grant.

F10 · derivative.exercise_price: This option was previously reported as an option for 2,000 shares of common stock at an exercise price of $68.25, but was adjusted to reflect the special dividend declared by PSB on December 15, 2014.

F10 · shares: This option was previously reported as an option for 2,000 shares of common stock at an exercise price of $68.25, but was adjusted to reflect the special dividend declared by PSB on December 15, 2014.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.